These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16801481)

  • 1. Aldosterone, dietary salt, and renal disease.
    Pimenta E; Calhoun DA
    Hypertension; 2006 Aug; 48(2):209-10. PubMed ID: 16801481
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction: Aldosterone and salt: heart and kidney.
    Young MJ; Fuller PJ; Stowasser M; Mihailidou AS
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):872-5. PubMed ID: 24117761
    [No Abstract]   [Full Text] [Related]  

  • 3. Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases.
    Queisser N; Schupp N
    Free Radic Biol Med; 2012 Jul; 53(2):314-27. PubMed ID: 22609249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salt, aldosterone and hypertension.
    Pimenta E; Gordon RD; Stowasser M
    J Hum Hypertens; 2013 Jan; 27(1):1-6. PubMed ID: 22785050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt Appetite and its Effects on Cardiovascular Risk in Primary Aldosteronism.
    Adolf C; Schneider H; Heinrich DA; Handgriff L; Reincke M
    Horm Metab Res; 2020 Jun; 52(6):386-393. PubMed ID: 32252107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
    Kawarazaki H; Ando K; Shibata S; Muraoka K; Fujita M; Kawarasaki C; Fujita T
    J Hypertens; 2012 Oct; 30(10):1977-85. PubMed ID: 22914542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.
    Morris RC; Schmidlin O; Sebastian A; Tanaka M; Kurtz TW
    Circulation; 2016 Mar; 133(9):881-93. PubMed ID: 26927006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldosterone, organ damage and dietary salt.
    Catena C; Colussi G; Sechi LA
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):922-8. PubMed ID: 23803228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension.
    Hall JE
    Circulation; 2016 Mar; 133(9):894-906. PubMed ID: 26927007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic hyperaldosteronism in cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice.
    Nugrahaningsih DA; Emoto N; Vignon-Zellweger N; Purnomo E; Yagi K; Nakayama K; Doi M; Okamura H; Hirata K
    Hypertens Res; 2014 Mar; 37(3):202-9. PubMed ID: 24108235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microalbuminuria in essential hypertension].
    Styczyński G; Loń I; Lapiński M
    Pol Arch Med Wewn; 1995 Nov; 94(5):451-5. PubMed ID: 8833945
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and extracellular fluid volumes in hypertension.
    Dustan HP; Tarazi RC; Bravo EL; Dart RA
    Circ Res; 1973 May; 32():Suppl 1:73-83. PubMed ID: 4712515
    [No Abstract]   [Full Text] [Related]  

  • 16. Aldosterone and cardiovascular disease: smoke and fire.
    Calhoun DA
    Circulation; 2006 Dec; 114(24):2572-4. PubMed ID: 17159070
    [No Abstract]   [Full Text] [Related]  

  • 17. [Case of primary aldosteronism associated with heart and kidney failure].
    Kano H; Orita S; Hirose M; Kawano M; Okamura M; Tani T; Minami M; Yokokawa A; Haraguchi M; Yasunari K; Yoshikawa J
    Nihon Naika Gakkai Zasshi; 1998 May; 87(5):922-4. PubMed ID: 9648444
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium and its multiorgan targets.
    Frohlich ED; Susic D
    Circulation; 2011 Oct; 124(17):1882-5. PubMed ID: 22025637
    [No Abstract]   [Full Text] [Related]  

  • 19. Aldosteronism and hypertension.
    Calhoun DA
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1039-45. PubMed ID: 17699324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal impact of primary hyperaldosteronism].
    Ribstein J
    Ann Cardiol Angeiol (Paris); 2004 Jun; 53(3):150. PubMed ID: 15291172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.